微波和^(32)P敷贴治疗跖疣近期疗效观察  被引量:7

Treatment of Verruca Plantaris with Microwave and ^(32)P Application Therapy

在线阅读下载全文

作  者:马玉波[1] 刘怡文[2] 陈美娟[2] 陆平[2] 

机构地区:[1]上海交通大学医学院附属仁济医院核医学科,上海200001 [2]上海交通大学医学院附属仁济医院皮肤科,上海200001

出  处:《中国皮肤性病学杂志》2007年第6期345-346,共2页The Chinese Journal of Dermatovenereology

摘  要:目的探讨微波和32P敷贴治疗跖疣的临床疗效及其应用价值。方法门诊随机选择跖疣患者161例并随机分成两组,微波治疗组65例局麻下微波去除疣体病灶;32P敷贴治疗组96例,将放射性核素32P液均匀滴于与病灶相同大小的纱布块上,晾干后将其固定于相应病灶表面进行敷贴治疗。每周敷贴1次,平均5~6次,至脱痂痊愈。观察和比较两组的临床反应和疗效。结果微波治疗组临床治愈率、复发率、副作用发生率、并发症发生率分别是36.9%,53.8%,80.0%和44.6%;32P敷贴治疗组分别是96.9%,3.1%,37.5%,15.6%。结论32P敷贴治疗足底跖疣较微波治疗方法简便安全,痛苦小,疗效显著,副作用少。Objective To study the clinical curative effect of verruca plantaris with microwave and ^32p Application and its application value, Methods 161 patients with extremity verruca plantaris were chosen by random from outpatient, Randomly divided them into two groups : (1)65 cases in microwave treatment group, the wart bodies were eliminated by microwave under local anaesthetize. (2)96 individuals were in ^32p application therapy group, the liquid of radionuclide ^32p were dropped in gauze, drying them and then fixing them in corresponding focus surface for application therapy. About 5 - 6 times, and once a week until the lesion recovered. The clinical reaction and curative effect were observed. Results The clinical cure rate,recurrence rate,side effective occurrence rate and complication occurrence rate were 36.9% ,53.8%, 80. 0% and 44.6% respectively in microwave treatment group and they were 96.9% ,3.1% ,37.5% and 15.6% respectively in the group of ^32p application therapy. Conclusion The characteristics of treatment of verruca plantaris, with ^32p application therapy are simple method , convenient, safety, little pain, notable curative effect,it is a kind of successful effective treatment method.

关 键 词: 跖疣 微波 ^32P 敷贴治疗 

分 类 号:R817.8[医药卫生—影像医学与核医学] R752.5[医药卫生—放射医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象